Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 3.65% is 77% below its 5-year average of 15.84%, near the low end of its 5-year range (3.65%–27.83%).
As of the fiscal period ended Tuesday, June 30, 2026. 60.32% below its 12-month average of 9.21%.
Reported quarterly debt to assets ratio; no daily interpolation. Q1 FY2027 (2026-06-30): 3.65%.
DEBT TO ASSETS RATIO
3.65%
DEBT TO ASSETS RATIO AVG TTM
9.21%
DEBT TO ASSETS RATIO AVG 3Y
12.46%
DEBT TO ASSETS RATIO AVG 5Y
15.84%
DEBT TO ASSETS RATIO AVG 10Y
15.66%
DEBT TO ASSETS RATIO AVG 15Y
13.29%
DEBT TO ASSETS RATIO AVG 20Y
10.56%
CURRENT VS TTM AVG
-60.32%
CURRENT VS 3Y AVG
-70.68%
CURRENT VS 5Y AVG
-76.93%
CURRENT VS 10Y AVG
-76.67%
CURRENT VS 15Y AVG
-72.51%
CURRENT VS 20Y AVG
-65.40%
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+3959.49%
vs the sector median at left
Aurora Cannabis Inc.
Market Cap
$282.77M
Debt to Assets Ratio
3.65%
TTM Avg
9.21%
3Y Avg
12.46%
5Y Avg
15.84%
Market Cap
$283.58M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$281.92M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$285.88M
Debt to Assets Ratio
0.11%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$286.39M
Debt to Assets Ratio
0.04%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$286.85M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$287.63M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$272.44M
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$293.47M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aurora Cannabis Inc. (ACB) | $282.77M | 3.65% | 9.21% | 12.46% | 15.84% |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $283.58M | 0.01% | N/A | N/A | N/A |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $281.92M | 0.02% | N/A | N/A | N/A |
| Abeona Therapeutics Inc. (ABEO)vs › | $285.88M | 0.11% | N/A | N/A | N/A |
| Standard BioTools Inc. (LAB)vs › | $286.39M | 0.04% | N/A | N/A | N/A |
| Sagimet Biosciences Inc. (SGMT)vs › | $286.85M | 0.01% | N/A | N/A | N/A |
| Indaptus Therapeutics, Inc. (INDP)vs › | $287.63M | 0.00% | N/A | N/A | N/A |
| Rocket Pharmaceuticals, Inc. (RCKT)vs › | $272.44M | 0.06% | N/A | N/A | N/A |
| Larimar Therapeutics, Inc. (LRMR)vs › | $293.47M | 0.03% | N/A | N/A | N/A |
| Scribe Therapeutics Inc. (SCTX)vs › | $271.05M | N/A | N/A | N/A | N/A |
Debt/Assets
3.7%
Debt/Equity
0.04
Current Ratio
5.36
Interest Coverage
-25.8x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 3.65% |
| 2026-03-31 | 3.97% |
| 2025-12-31 | 13.03% |
| 2025-09-30 | 13.26% |
| 2025-06-30 | 12.13% |
| 2025-03-31 | 12.27% |
| 2024-12-31 | 11.65% |
| 2024-09-30 | 12.48% |
| 2024-06-30 | 12.17% |
| 2024-03-31 | 12.49% |
| 2023-12-31 | 12.65% |
| 2023-09-30 | 15.52% |
| 2023-06-30 | 18.79% |
| 2023-03-31 | 24.56% |
| 2022-12-31 | 22.08% |
| 2022-09-30 | 27.83% |
| 2022-06-30 | 23.96% |
| 2022-03-31 | 18.79% |
| 2021-12-31 | 24.56% |
| 2021-09-30 | 22.08% |
| 2021-06-30 | 14.66% |
| 2021-03-31 | 16.96% |
| 2020-12-31 | 17.43% |
| 2020-09-30 | 18.39% |
| 2020-06-30 | 18.14% |
| 2020-03-31 | 12.56% |
| 2019-12-31 | 12.89% |
| 2019-09-30 | 14.19% |
| 2019-06-30 | 11.72% |
| 2019-03-31 | 11.52% |
| 2018-12-31 | 7.13% |
| 2018-09-30 | 5.87% |
| 2018-06-30 | 10.64% |
| 2018-03-31 | 12.51% |
| 2017-12-31 | 0.04% |
| 2017-09-30 | 22.03% |
| 2017-06-30 | 19.80% |
| 2017-03-31 | 11.48% |
| 2016-12-31 | 25.23% |
| 2016-09-30 | 29.64% |
| 2016-06-30 | 58.09% |
| 2016-03-31 | 22.82% |
| 2015-12-31 | 11.48% |
| 2015-09-30 | 25.23% |
| 2015-06-30 | 29.64% |
| 2015-03-31 | 58.09% |
| 2014-12-31 | 44.30% |
| 2014-09-30 | 56.22% |
| 2014-06-30 | 26.52% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
